Association between pre-ptca blood haemoglobin concentration and the risk of symptomatic restenosis after successful ptca of primary coronary stenoses

European Journal of Cardiovascular Prevention & Rehabilitation

Volumn 4, Issue 1, 1997, Pages 37-40

  Gustavsson, Carl Gunnar ^a   Persson, Stig ^a   Thorvinger, Bjã¶rn O S ^a   Hedner, Pavo ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

blood viscosity; coronary disease; erythrocytes; haemoglobin; percutaneous transluminal coronary angioplasty; recurrence

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ARTICLE; BLOOD VISCOSITY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; DISEASE PREDISPOSITION; ERYTHROCYTE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTENOSIS; RISK FACTOR; THROMBOCYTE ADHESION; THROMBOGENESIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADULT; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD VISCOSITY; CASE-CONTROL STUDIES; CORONARY DISEASE; CORONARY THROMBOSIS; FEMALE; HEMOGLOBINS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; RECURRENCE; RISK FACTORS; SEX FACTORS;

EID: 0030876774     PISSN: 17418267     EISSN: 17418275     Source Type: Journal    
DOI: 10.1177/174182679700400107     Document Type: Article

References (11)

1. Topol EJ, Califf RM, Weisman HF, Ellis SG, Tcheng JE, Worley S etal: Randomised trial of coronary intervention with antibody against platelet ∗IIb/IIIa integrin for reduction of clinical restenosis: Results at six months Lancet 1994, 343: 881–886.
2. Schwartz RS, Holmes DR, Topol EJ: The restenosis paradigm revisited: An alternative proposal for cellular mechanisms J Am Coll Cardiol 1992, 20: 1284–1293.
3. Scotti TM: Disturbances of body water and electrolytes and of circulation of blood. In Pathology, 6th ed. Edited by Anderson WAD. St Louis: CV Mosby Company; 1971: 96–144.
4. Gustavsson CG, Persson SU, Larsson H, Persson S: Blood viscosity in relation to blood haemoglobin concentration in healthy subjects and in patients with different cardiovascular diseases Clin Hemorheology 1994, 14: 677–683.
5. Spahn DR, Smith LR, Veronee CD, McRae RL, Hu W, Menius AJ etal: Acute isovolemic hemodilution and blood transfusion. Effects on regional function and metabolism in myocardium with compromised coronary blood flow J Thorac Cardiovasc Surg 1993, 105: 694–704.
6. Lowe GDO: Blood rheology in arterial disease Clin Sci 1986, 71: 137–146.
7. Gagnon DR, Ting-Jie Z, Brand FN, Kannel WB: Hematocrit and the risk of cardiovascular disease — the Framingham study: A 34-year follow-up Am Heart J 1994, 127: 674–682.
8. Ryan TJ, Bauman WB, Kennedy JW, Kereiakes DJ, King SB III, McCallister BD etal: Guidelines for percutaneous transluminal coronary angioplasty: A report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures Circulation 1993, 88: 2987–3007.
9. Mintz GS, Kovach JA, Pichard AD, Kent KM, Satler LS, Popma JJ etal: Geometric remodelling is the predominant mechanism of clinical restenosis after coronary angioplasty. J Am Coll Cardiol 1994, (special issue):138A.
10. Holmes DR, Vlietstra RE, Smith HC, Vetrovec GW, Kent KM, Cowley MJ etal: Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA registry of the national heart, lung, and blood institute Am J Cardiol 1984, 53: 77C–81C.
11. Cowley MJ, Mullin SM, Kelsey SF, Kent KM, Gruentzig AR, Detre KM etal: Sex differences in early and long-term results of coronary angioplasty in the NHLBI PTCA registry Circulation 1985, 71: 90–97.